Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney; Complications, Allograft”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Large-scale testing (Phase 3)Study completedNCT00273871
What this trial is testing

Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 190
Not applicableStudy completedNCT01353417
What this trial is testing

Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection

Who this might be right for
Chronic Kidney Insufficiency
Sandoz 102
Large-scale testing (Phase 3)Study completedNCT00817206
What this trial is testing

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

Who this might be right for
Renal Failure
Veloxis Pharmaceuticals 326
Testing effectiveness (Phase 2)Looking for participantsNCT05027906
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

Who this might be right for
Prevention of Rejection in Kidney Transplant
Eledon Pharmaceuticals 48
Testing effectiveness (Phase 2)Ended earlyNCT00497926
What this trial is testing

Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion

Who this might be right for
Kidney Failure
Talaris Therapeutics Inc. 37
Early research (Phase 1)WithdrawnNCT04388761
What this trial is testing

Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)

Who this might be right for
Ischemia Reperfusion Injury
Tambi Jarmi
Not applicableStudy completedNCT01009229
What this trial is testing

A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?

Who this might be right for
Renal FailureRenal TransplantationLiving Donors
Insel Gruppe AG, University Hospital Bern 100
Large-scale testing (Phase 3)Study completedNCT03018041
What this trial is testing

The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation

Who this might be right for
Kidney Transplantation
Joe Chan 174
Testing effectiveness (Phase 2)Study completedNCT00446459
What this trial is testing

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 45
Not applicableStudy completedNCT03984747
What this trial is testing

Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection

Who this might be right for
Transplant RejectionAllograft RejectionComplications
Natera, Inc. 110
Early research (Phase 1)UnknownNCT05195125
What this trial is testing

Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients

Who this might be right for
End Stage Liver DIseaseObesityAcute Kidney Injury
University of Colorado, Denver 15
Not applicableEnrolling By InvitationNCT05058170
What this trial is testing

Renal Allograft Fibrosis Study

Who this might be right for
Renal Allograft Fibrosis
Icahn School of Medicine at Mount Sinai 162
Large-scale testing (Phase 3)Study completedNCT01187953
What this trial is testing

Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx

Who this might be right for
Renal Failure
Veloxis Pharmaceuticals 543
Testing effectiveness (Phase 2)Study completedNCT00801632
What this trial is testing

Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

Who this might be right for
Kidney TransplantationKidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Looking for participantsNCT07053462
What this trial is testing

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Who this might be right for
End-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Post-approval studies (Phase 4)Study completedNCT00266123
What this trial is testing

Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 420
Testing effectiveness (Phase 2)UnknownNCT00498160
What this trial is testing

Induction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell Infusion

Who this might be right for
Renal Failure
Talaris Therapeutics Inc. 38
Post-approval studies (Phase 4)Study completedNCT01820897
What this trial is testing

Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation

Who this might be right for
Urinary Tract InfectionAsymptomatic BacteriuriaAllograft Rejection+2 more
JOSE MANUEL ARREOLA GUERRA 130
Testing effectiveness (Phase 2)Study completedNCT04696146
What this trial is testing

Berinert (C1INH) vs Placebo for DGF/IRI

Who this might be right for
End Stage Renal DiseaseChronic Kidney Diseases
Cedars-Sinai Medical Center 45
Next Page